Kodi pali phindu lenileni logwiritsa ntchito cannabidiol kapena CBD? Ili ndi funso lomwe likufunsidwa mochulukira padziko lonse lapansi ngakhale zotsatira zabwino zoyambirira zomwe zawonedwa. Kafukufuku akuwonetsa kuti cannabidiol imawonetsa kwambiri antivayirasi, makamaka ikafika poteteza thupi ku kachilombo ka hepatitis C.
ANNABIDIOL, MANKHWALA OGWIRITSA NTCHITO PA VUTO LA CHIWEREMBO C?
Akuti osachepera 20 aku America adzafa ndi khansa ya chiwindi, ambiri mwa iwo amachokera ku HCV. Kafukufuku watsopano wa CBD ndi zotsatira zake pa chiwindi akuwonetsa kuti cannabis imalepheretsa kachilombo ka hepatitis. Kuti kafukufuku wa 2017 amawulula kuti CBD, mmodzi wa mankhwala waukulu chamba, amaonetsa kwambiri sapha mavairasi oyambitsa katundu, makamaka pankhani kuteteza thupi ku matenda a chiwindi C HIV.
Phunzirolo, lochitidwa ndi a Dr. Lowe, pulofesa ku yunivesite ya Maryland School of Medicine, yomwe yasindikizidwa mu Pharmacognosy Research Journal yolemekezeka kwambiri. Amasonyeza kuti cannabidiol ikhoza kukhala chithandizo chamankhwala kwa anthu oposa 3 miliyoni aku America omwe akudwala kachilombo ka hepatitis C. Ofufuza omwe adachita kafukufukuyu anapeza kuti phytochemical, CBD, imalepheretsa kachilombo ka hepatitis C. hepatitis C, ndipo nthawi zambiri imakhala yoletsa tizilombo toyambitsa matenda.
Mwachikhalidwe, zikafika pakuphunzira za CBD, anti-yotupa, neuroprotective, ndi antioxidant katundu ndi omwe amafufuzidwa. Phunziro ili
zatsopano zayang'anitsitsa kwambiri CBD. Makamaka ngati antiviral wothandizira, ndipo zotsatira zake zinali zokhutiritsa.
Dr. Lowe ndi anzake adaphatikiza CBD ndi kachilombo ka hepatitis C pansi pa ma laboratory. Izi ndikuzindikira kuti anapatula Cannabidiol adaletsa kufalikira kwa kachilombo ka hepatitis C ndi 86,4% ndi pulogalamu imodzi yokha. Mwakutero, kafukufukuyu adatsimikiza kuti zotsatira zowononga ma virus za CBD zitha kukhala zothandiza kuthana ndi matenda a chiwindi omwe sanatchulidwepo, omwe amadziwika kuti autoimmune hepatitis.
Ngakhale ofufuza sanawone zotsatira za antiviral za CBD pa kachilombo ka hepatitis B (HBV) mu vitro. Adawonetsa kuti, kutengera kafukufuku wina wazachipatala, cannabidiol itha kukhala antiviral motsutsana ndi hepatitis C mu vivo. Makamaka kupyolera mu kayendetsedwe ka CB2 zolandilira m'thupi, kuyankhidwa kwabwino kwa chitetezo cha mthupi ku kachilombo ka hepatitis C ndi kachilombo ka hepatitis C kumatha kuwonedwa.
gwero : blog-cannabis.com/ - ncbi.nlm.nih.gov/
